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Congestive heart failure is a serious medical condition man- 
ifested by signs and symptoms of abnormal cardiac ventric- 
ular performance. Many forms of heart disease may lead to 
congestive heart failure. Because of its potential medical nd 
economic impact, estimating the national prevalence and 
mortality of congestive heart failure is important in the 
health planning process. 
Earlier descriptions of congestive h art failure prevalence 
in the United States are surprisingly scarce and constructed 
from limited data sets. Estimates of period prevalence, 
including small surveys, hospital records and death certifi- 
cates. produced widely varying figures (0.05 to 1311,000) 
(1-6). The Framingham Heart Study (7,8) estimated the 
prevalence of congestive heart failure to be between 3 and 
IO/P,000 in its local population sample. Hospital discharge 
data (35) have identified numbers of patients whose illness 
required hospitalization. No prior investigation has exam- 
ined the prevalence of congestive heart failure for the entire 
nation. Therefore, we used nationally representative data 
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increase with advanci 
collected by the first National Health and Nutrition Exami- 
) and follow-up examinations to 
investigate he prevalence and mortality rate of congestive 
heart failure in the U.S. 
ANES egun in 1971 as a successor to
the National Health Examination Surveys (NHES), the 
NHANES-I program evaluated 23,808 ~oni~stit~tiomalized 
persons from 1 to 74 years old identified emographically 
throughout the U.S. (9-11). The study design included 
oversampling of specific population subgroups, women of 
childbearing a e, the lderly and persons living in poverty. 
The initial adult cohort consisted of 14,407 persons 25 to 74 
years old. Evaluation occurred between 1971 and 1975 and 
included medical and nutritional history, physical examina- 
tion and, in many cases, blood an  urine tests, r!ectrocar- 
diography, chest X-ray films, spirometry and visual exami- 
nations of the initial group (12-15). 
Self-reported prevalence of congestive heart failure was 
derived from responses to the medical history questionnaire. 
Data used to construct the clinical scoring system for con- 
gestive heart failure, described in the following section, were 
extracted from the detailed nealth examination f 6,913 men 
and women of the original cohort who completed the de- 
tailed health examination (12-15). 
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Mortality data were derived from the NHANES-I Epide- 
miologic Followup Study, waves I (1982 to 1984) and II 
(1986). The extensive and thorough follow-up rocedures 
have been described elsewhere (16,17). Briefly, all subjects 
25 to 74 years old at NHANES-I examination in 1971 to1975 
were contacted between 1982 and 1984 to determine fol- 
low-UP status. Although 1,024 were not traced, death was 
verified in 2,022 of the remaining 13,383 subjects and the 
cause of death was established byproxy interview (4.3%) or 
death certificate (16.1%). or both (79.6%). 
In 1986 all subjects who had been 255 years old at he 
time of the NHANES-I examination a d were alive at the 
time of the 1982 to 1984 follow-up (n = 3,980) were resur- 
veyed, 6f this group, 213 were not traced and 635 had died, 
with 3,132 survivors. Mortality due to congestive heart 
failure as presented in this report is therefore expressed as
IO-year mortality rate for subjects in the 25- to 54.year age 
group and as IO- and 15.year mortality rate in the 55- to 
64-year nd the 6.5- to74.year ge groups. 
Definitions of congestive heart failure. For purposes of 
this study, congestive h art failure was defined in two ways. 
First, participants were asked on a self-report questionnaire 
if they had ever, in the past or currently, been told by a 
physician that hey had heart failure. An operative definition 
of congestive h art failure, based on criteria developed by 
the Framingham Heart Study (7), was also used. These 
criteria were amended by considering clinical variables u ed 
to define heart failure in a large group of patients with 
coronary artery disease (18). The definition was further 
modified to fit the NHANES-I detailed health examination 
collecting methodology (12-15). Dyspnea inthe NHANES-I 
detailed health examination was assessed by questions 
adapted from the World Health Organization Dyspnea Ques- 
tionnaire (19). The scoring of congestive h art failure sever- 
ity was derived from Framingham ethodology (7) along 
clinical lines used in an evaluation f digoxin efficacy inheart 
C&ue (20). In the present scoring system, for purposes of 
analysis, congestive heart failure was defined as a total 
congestive h art failure score of 23 (Table I). 
In keeping with the NHANES-I survey design, data were 
weighted on the basis of probability of selection i to the 
sample as coefficients o convert he sample figures into 
national estimates (12-15). Some very minor discrepancies 
in accounting for the completeness of the sample are due to 
exclusion of subjects from analysis because of incomplete 
data (incomplete clinical examination data or questionnaire 
responses). 
TO estimate maximal nd minimal effects of these discrep- 
ancies on the survey observations, all prevalence and mor- 
tality analyses were performed in two ways. One set of trial 
calculations a sumed that all missing data came from sub- 
jects with congestive heart failure who had ied at the time 
of follow-up. A second set assumed that all missing data 
came from persons without congestive heart failure who 
were alive at fOIk)w-up. The greatest difference between the 
data s collected and the calculations based on assumptions 
Table I. Heart Failure Clinical Score 
Clinical Variables Score 
Dyspnea/difficulty breathing 
Trouble with breathing (shortness of breath) 
Hurrying on the level or up slight hill 
At ordinary pace on the level? 
Do you stop for breath when walking at own pace? 
Do you stop for breath after 100 yards on the level? 
Physical examination 
Heart rate (beatslmin) 
9! to II0 
Ill+- 
Raleslcrackles 
Either lower lung field 
Either lower and either upper lung field 
Jugulovenous distension 
Alone 
Plus edema 
Plus hepatomegaly 
Chest X-ray film 
I 
I 
2 
2 
I 
2 
I 
2 
I 
2 
2 
Cephalization of pulmonary vessels I 
Interstitial edema 2 
Alveolar fluid plus pleural fluid 3 
Interstitial edema plus pleural fluid 3 
for missing data was 0.2%. This difference was judged too 
small to justify additional d ta analysis and discussion. 
Relation of prevalence of congestive heart fissure to age. 
The prevalence of self-reported congestive heart failure is 
related to age and does not appear to differ greatly between 
men and women (Table 2, Fig. 1). Based on a U.S. popula- 
Table 2. Estimated Congestive Hear& Failure Prevalence as 
Assessed by Self-Report and Clinical Score. Noninstitutionalized 
U.S. Population 25 to 74 Years of Age. NHANES-I (1971-1975) 
Gender and Age 
(yr! 
Women 
22 to 54 
5s to 64 
65 to 74 
Total 25 to 74 
Men 
25 to 54 
55 to 64 
65 to 74 
Total 25 to 74 
Women and men 
25 to 54 
55 to 64 
65 to 74 
Total 25 to 74 
Self-Report 
Estimated 
Prevalence No. of 
% Cases 
0.3 128,150 
2 202,508 
3.2 229,504 
I 560.162 
0.4 143,758 
2.2 195,981 
3.7 203,704 
I.1 543,443 
0.4 271,908 
2.1 398,489 
3.4 433,208 
1.1 1,103,605 
Clinical Score 
Estimated 
Prevalence No. of 
% Cases 
1.3 500,990 
3 303,137 
4.3 316,861 
2 I, 120,988 
0.8 295,477 
4.5 407,306 
4.8 273,713 
1.9 976,496 
1.1 796,467 
3.7 710,443 
4.5 590,574 
2 2,097&l 
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re 1. Prevalence of congestive heart failure as assessed by 
self-report  score (23) by gender and age group. 
tion estimate for the survey time period, the total ~~rnber of 
o~i~st~t~~t~o~alize~ 
percentage is undoubtedly big when the older and insti- 
tutionalized (including nursing homes) portion of the popu- 
lation is added. 
By clinical definition, total score increased as congestive 
heart failure symptoms and signs increased. The prevalence 
of subjects with a c art failure score 23 (or 
self-reported congestiv rc) was strongly related to 
age (Fig. 1). Based on (Table 2), the nationwide 
prevalence ofcongestive heart failure during the period of 
the NHAI+JES-I survey is app ately 2% or 2.1 million 
ortality due to congestive 
heart failure was assessed attwo points in time. To establish 
lo-year mortality, comparisons were made between those 
subjects evaluated at NHANES-I and located at the first 
NHANES follow-up. Mortality is presented here as the 
proportion of deaths among those who had congestive heart 
failure by self-report or a score ~3 (Table 3, Fig. 2). 
Fifteen-year mortality was based on the second NHANES 
follow-up only for those >54 years old at the initial exami- 
nation (Fig. 3). 
With reference tothe self-reported diagnosis of conges- 
tive heart failure, lo-year mortality increased with age when 
considered as total mortality (Table 3, Fig. 2). Similarly, 
when defined by congestive heart failure severity score, 
lo-year mortality rates demonstrate a generally continuous 
and positive relation t  age and score for both women and 
men (Table 3, Fig. 2). 
The lo-year total mortality rate for men with self-reported 
congestive heart failure exceeded that for women (49.8% 
compared with 36%, Table 3). However, the mortality rate 
for men and women without self-reported congestive heart 
failure was much lower (12.6% and 7.5%, respectively). 
Similar observations were derived from congestive heart 
le 3. Estimated IO-Year Total 
Conges Failure as Assessed by Self- 
Score. tionalized U.S. ~o~~lat~oa 2 14 Year5 of 
Age. N Follow-Up ~~9~2-~9$4) 
Gender and Age 
:yr) 
Total Mortality 
Self-Repu-l Clinical Score 
Estimated Estimated 
No. of No. of 
% Deaths % Deaths 
25 to 54 
55 IO 64 
65 to 14 
Total 25 IO 74 
Men 
25 to 54 
55 IO 64 
65 to 74 
Total 2.5 to 74 
Women and men 
25 to 54 
55 10 64 
65 to 74 
Total 25 to 74 
6.3 8,102 2.3 61,538 
29.4 52,608 15 39,53 1 
59.5 126,119 49.9 153,682 
36 186,829 23.8 254,75 1 
25.4 36,505 28.6 84,352 
45.3 77,855 63.8 238,147 
71.8 139,201 13.5 157,512 
49.8 253,561 54.4 480.011 
16.4 44,607 18.3 145,890 
37.2 130.463 43.6 277,678 
45.4 265,320 59.6 391,194 
42.8 440.390 37.6 734,762 
failure scores. Tbe mortality rate over 10 years of 
sons with a congestive h t failure score r3 was 
for men and 23.8% fo en (Table 3). For those 
clinical score <3 (no stive heart failure), the 
mortality rate over lo-year follow-up eriod was 10.2% for 
lity rate at IS years. The second N 
rmed in 1986, provi ed additional data 
Figure 2. Ten- and fifteen-year mortality rates of self-reported 
congestive heart failure (CWF). A = 25 to 44 years, = 55 to 64 
years, C = 65 to 74 years. 
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Flgure 3. Ten- and fifteen-year mortality of congestive heart failure 
(CHF) assessed try score (13). A = 25 to 54 years, B = 55 to 64 
years, C = 65 to 74 years. 
on the 15-year mortality rate of persons with congestive 
heart failure. The follow-up data co!lcction protocol was 
restricted topersons in the upper age groups. The 15-year 
total mortality rate for self-reported congestive h art failure 
in participants 65to 74 years old is 73.2% for men and 62.6% 
for women (Fig. 3). This rate is slightly increased over the 
IO-year mortality rate of 71.8% for men and 59.5% for 
women (Table 3. Fig. 2). 
The 15.year total mortality rate for congestive heart 
failure based on an initial clinical severity score of ~3 was 
parallel with that noted for self-reported congestive heart 
failure (Table IV, Fig. 3). In the 65 to 74 age group, the 
15.year mortality rate based on a congestive heart f ilure 
severity score of a3 was 51.4% for women and 79.3% for 
men (Table IV, Fig. 31, compared with 37.2% and 52.1%, 
respectively, for women and men with a score of 0 to 2. 
These latter two rates are quite similar to the mortality rates 
of 39.9% and 56.2%, respectively, over 15 years in the 
self-report group with no personal history of congestive 
heart failure. 
ity rates for younger patients and those with heart 
disease. The lO- and 15-year mortality rates for younger age 
groups and for patients with heart disease, as well as for 
those with coronary heart disease, were more disparate 
when compared by gender and between the two definitions 
of congestive h art failure, largely because ofthe low event 
rates in each of these groups, and did not produce meaning- 
ful results. 
The present study reveals that congestive heart failure is 
not uncommon i  the U.S., affecting 1 to 2 million persons or 
Tahle 4. Estimated IS-Year Total Mortalit~~ for Persons With 
Conges!ive Heart Failure as Assessed by Self-Report and Clinical 
Score. Noninstitutionalized U.S.Population 25 to 74 Years Old. 
NHANES-I Follow-Up (1986) 
Total Mortality 
Self-Report Clinical Score 
Estimated Estimated 
Gender and Age No. of No. of 
(yr) % Deaths % Deaths - 
WOl~~~U 
5s to 64 37.6 76,068 26.2 79,442 
65 lo 74 62.6 143.619 51.4 162,215 
Total 55 to 74 5tl.S 219,687 39. I 242.257 
Men 
55 to 64 52 101,897 66.8 27 I ,9;S 
65 to 74 13.2 149,060 79.3 216.940 
‘rotai 55 t0 74 62.8 250,957 71.8 4SS,W3 
Women and Men 
55 to 64 44.1 177,965 49.5 35 1,405 
65 to 74 67.6 ““9?,6?9 64.3 379.755 
Total 55 to 94 56.6 470,644 56.2 731,160 
~~,_^--- I. - I-. --.__ I-- ~- 
1.1 to 2 percent of noninstitutionalized adults. This condition 
is not benign. Overall, IO-year and 15-year mortality rates 
for those with congestive heart failure (by self-report or 
heart failure score 23) are >55% for all those 55 to 74 years 
old and are worse for those 65 to 74 years old, approaching 
70% at 15 years of follow-up for the combined group of men 
and women in this older age group. To place these findings in 
perspective, comparisons should be drawn on the basis of 
previous reports. 
Comparison with previous studies. Early st’udies ofcon- 
gestive heart failure were hindered by difficulties indiagnos- 
tic labeling. Self-report of recalled patient diagnosis may 
lead to problems with both under- and overestimates. There- 
fore, development of a diagnostic method rawing on data 
collecaed from several sources will likely improve diagnostic 
accuracy. Within the constraints of the NHANES detailed 
health examination methods, the definition of congestive 
heart failure used in this study was taken from both epide- 
miologic studies of heart failure (7,19) and clinical studies of 
digoxin efficacy in congestive h art failure management (18). 
In contrast, a less specific set of clinical criteria have been 
used in a Swedish study of men born in 1913 (21,22). By their 
definition, so-called early or latent heart failure was present 
in 10% of their sample, whereas another 13% had overt heart 
fdilure, yielding atotal prevalence of 23%, much higher than 
that. in the present study. 
Although valuable, findings from Framingham are de- 
rived from a small, geographically selected semi-urban pop- 
ulation sample (7). The older data ofGibson et al. (2) were 
obtained from two rural physician practices in she casterr? 
U.S. Use of hospitai records and death certificates carries its 
own inherent bias toward sicker, hospitalized persons. 
Klainer et al. (1) also used community and physician surveys 
as sources, a method that better approaches true prevalence. 
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tensiwi i25.2h) and ischemic or ~~~~~~ltb~c dilated cardiomy 
opathy (27). Some s’rudies have excluded the sickest per- 
sons, se!ec:ing sitbjects based on other clinical grounds 
study. These varied observations partly ex- 
ences between the present study and 
tionwide survey of 
to eliminate d mo- 
graphic bias as far as practical. The data pr 
not address nonwhites separately because 
ience of congestive heart failure in the s 
nonwhites precluded ea~~~g~~~ analysis. 
The congestive heart failure mortality rates presented 
here are based on patients who died after I diagnosis of 
congestive heart failure, not those whose death certificate 
listed heart failure (I -9 Code 428) as the cause of death. 
This approach was c en for several reasons. First, as the 
primary diagnosis from death certificates, heart failure was 
uncommon (29 subjects after I5 years of fol~ow~~~). Secon 
heart failure is both a concomitant ofmultiple other illness 
and a common associated illness in patients dying from a 
wide variety of other problems (such as sudden cardiac 
death, pneumonia and myocardial infarction). It was be- 
lieved that otal mortality irrespective of cause of death label 
would give a more accurate picture of the true mortality rate 
of this ploblem, essentially adjusting for vagaries inlabeling 
primary cause of death. 
ications. Congestive heart faiiure is 
neither rare nor benign. Its real and potential impact on the 
allocation of health care resources i  significant. Some 
encouraging trials have demonstrated that drug efficacy has 
improved functional capacity and survival in patients with 
congestive heart failure (30-34). 
Several important epidemiologic questions persist. What 
roles do the traditional risk factors for atherosclerotic car- 
diovascular disease play in the tiology of congestive heart 
failure? Some data are available r garding the potent role of 
hypertension (26), but the contributions of cigarette smok- 
ing, lipid status and other risk factors are not well estab- 
lished. Once congestive heart failure is present, how is its 
course influenced by these or other unrecognized clinical 
risk factors or markers of morbidity and mortality? What 
influence might other untested rugs or nonpharmacologic 
modes of therapy have on mortality, morbidity and quality of 
life in patients with heart failure? 
For the moment, hese questions remain largely nmm- 
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